Cargando…

Network pharmacology reveals the multiple mechanisms of Xiaochaihu decoction in the treatment of non-alcoholic fatty liver disease

BACKGROUND: Non-alcoholic fatty liver (NAFLD) is a chronic disease worldwide, which poses a huge threat to human health. Xiaochaihu decoction is a well-known traditional Chinese medicine prescription. It has been proven effective in treating NAFLD but its mechanism is still unclear. OBJECTIVE: Multi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Qichao, Wei, Shizhang, Wen, Jianxia, Zhang, Wenwen, Jiang, Yinxiao, Qu, Caiyan, Xiang, Junbao, Zhao, Yanling, Peng, Xi, Ma, Xiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450930/ https://www.ncbi.nlm.nih.gov/pubmed/32863886 http://dx.doi.org/10.1186/s13040-020-00224-9

Ejemplares similares

Uncovering the Pharmacology of Xiaochaihu Decoction in the Treatment of Acute Pancreatitis Based on the Network Pharmacology
por: Zhan, Lianghui, et al.
Publicado: (2021)

Systems pharmacology dissection of pharmacological mechanisms of Xiaochaihu decoction against human coronavirus
por: Xu, Lvjie, et al.
Publicado: (2023)

Mechanisms of Xiaochaihu Decoction on Treating Hepatic Fibrosis Explored by Network Pharmacology
por: Qiang, Rui, et al.
Publicado: (2022)

Paeoniflorin, a Natural Product With Multiple Targets in Liver Diseases—A Mini Review
por: Ma, Xiao, et al.
Publicado: (2020)

Xiaochaihu decoction for nonalcoholic fatty liver disease: A protocol for a systematic review and meta-analysis
por: Zhu, Wenyu, et al.
Publicado: (2021)

Effects of Xiaochaihu decoction on the expression of cytochrome P450s in rats
por: Li, Hongfang, et al.
Publicado: (2021)

New treatment for gastroesophageal reflux disease: Traditional Chinese medicine Xiaochaihu decoction
por: Xu, Li-Ying, et al.
Publicado: (2022)

Xiaochaihu Decoction Treatment of Chicken Colibacillosis by Improving Pulmonary Inflammation and Systemic Inflammation
por: Song, Ke, et al.
Publicado: (2022)

Efficacy and safety of Xiaochaihu decoction for subacute thyroiditis: A protocol of systematic review and meta-analysis
por: Li, Linzhi, et al.
Publicado: (2020)

Modified Xiaochaihu Decoction for gastroesophageal reflux disease: A randomized double-simulation controlled trial
por: Li, Zhe, et al.
Publicado: (2021)

Modified Xiaochaihu Decoction Combined with Mirtazapine in the Treatment of Persistent Depression: A Pilot Randomized Controlled Trial
por: Li, Xin, et al.
Publicado: (2022)

Flavonoids on diabetic nephropathy: advances and therapeutic opportunities
por: Hu, Qichao, et al.
Publicado: (2021)

Tripterygium hypoglaucum (Lévl.) Hutch and Its Main Bioactive Components: Recent Advances in Pharmacological Activity, Pharmacokinetics and Potential Toxicity
por: Zhao, Junqi, et al.
Publicado: (2021)

Clinical Efficacy and Safety of Shashen Maidong Decoction in the Treatment of Pediatric Mycoplasma Pneumonia: A Systematic Review and Meta-Analysis
por: Wang, Jiawei, et al.
Publicado: (2021)

Mechanism of Paeoniflorin in the Treatment of Bile Duct Ligation-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology
por: Wei, Shizhang, et al.
Publicado: (2020)

Research Progress and Treatment Status of Liver Cirrhosis with Hypoproteinemia
por: Wen, Jianxia, et al.
Publicado: (2022)

Effect of modified Xiaochaihu decoction-containing serum on HepG2.2.15 cells via the JAK2/STAT3 signaling pathway
por: Chen, Shaofang, et al.
Publicado: (2017)

Potential therapeutic effect of Qingwen Baidu Decoction against Corona Virus Disease 2019: a mini review
por: Wen, Jianxia, et al.
Publicado: (2020)

Xiaochaihu Decoction attenuates the vicious circle between the oxidative stress and the ALP inactivation through LPS-catecholamines interactions in gut, liver and brain during CCI(4)+ethanol-induced mouse HCC
por: Liu, Xiao-qiu, et al.
Publicado: (2013)

Evaluation preparation technology of Xiaochaihu granules using fingerprint-peak pattern matching
por: Wu, Yu-Qiong, et al.
Publicado: (2011)

Comparative Evidence for Intrahepatic Cholestasis of Pregnancy Treatment With Traditional Chinese Medicine Therapy: A Network Meta-Analysis
por: Jiang, Yinxiao, et al.
Publicado: (2021)

Preclinical Evidence of Berberine on Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Animal Studies
por: Ren, Sichen, et al.
Publicado: (2021)

Metabolomics Profiles Reveal the Efficacy of Wuzhuyu Decoction on Patients with Chronic Non-Atrophic Gastritis
por: Hu, Qichao, et al.
Publicado: (2023)

Xiaochaihu decorction relieves liver fibrosis caused by Schistosoma japonicum infection via the HSP47/TGF-β pathway
por: Huang, Yuzheng, et al.
Publicado: (2020)

Astragali Radix Contributes to the Inhibition of Liver Fibrosis via High-Mobility Group Box 1-Mediated Inflammatory Signaling Pathway
por: Wen, Jianxia, et al.
Publicado: (2021)

Extraction Efficiency of Shosaikoto (Xiaochaihu Tang) and Investigation of the Major Constituents in the Residual Crude Drugs
por: Sumino, Megumi, et al.
Publicado: (2012)

Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
por: Francque, Sven, et al.
Publicado: (2019)

A Study on the Therapeutic Efficacy of San Zi Yang Qin Decoction for Non-Alcoholic Fatty Liver Disease and the Underlying Mechanism Based on Network Pharmacology
por: Li, Yiping, et al.
Publicado: (2021)

Exploring the Protective Effects and Mechanism of Huaji Jianpi Decoction against Nonalcoholic Fatty Liver Disease by Network Pharmacology and Experimental Validation
por: Xue, Hongkun, et al.
Publicado: (2022)

Integrating Network Pharmacology and RT-qPCR Analysis to Investigate the Mechanisms Underlying ZeXie Decoction-Mediated Treatment of Non-alcoholic Fatty Liver Disease
por: Wu, Jiashuo, et al.
Publicado: (2021)

Identify Molecular Mechanisms of Jiangzhi Decoction on Nonalcoholic Fatty Liver Disease by Network Pharmacology Analysis and Experimental Validation
por: Wang, Lei, et al.
Publicado: (2020)

Network Pharmacology-Based Antioxidant Effect Study of Zhi-Zi-Da-Huang Decoction for Alcoholic Liver Disease
por: An, Li, et al.
Publicado: (2015)

Effect of traditional Chinese medicine (Xiaochaihu Tang) on the expression of MMP-2 and MMP-9 in rats with endometriosis
por: JIAO, LUYANG, et al.
Publicado: (2013)

Mechanical Study of Jian-Gan-Xiao-Zhi Decoction on Nonalcoholic Fatty Liver Disease Based on Integrated Network Pharmacology and Untargeted Metabolomics
por: Cao, Yong-Jun, et al.
Publicado: (2022)

Current and emerging pharmacological therapy for non-alcoholic fatty liver disease
por: Eshraghian, Ahad
Publicado: (2017)

Quantitative Determination of 7 Saikosaponins in Xiaochaihu Granules Using High-Performance Liquid Chromatography with Charged Aerosol Detection
por: Liu, Aoxue, et al.
Publicado: (2021)

Mechanism of Paeoniflorin on ANIT-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology
por: Chen, Lisheng, et al.
Publicado: (2021)

Pharmacological management of non-alcoholic fatty liver disease: Atorvastatin versus pentoxifylline
por: Cioboată, Ramona, et al.
Publicado: (2017)

Research on the Mechanism of Qushi Huayu Decoction in the Intervention of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking Technology
por: Gao, Shan-shan, et al.
Publicado: (2020)

Eight Zhes Decoction ameliorates the lipid dysfunction of nonalcoholic fatty liver disease using integrated lipidomics, network pharmacology and pharmacokinetics
por: Zhou, Yuping, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p6jhjcudf5geaolitabj23oh0e